-D) as well as the first and only approved Factor Xa inhibitor reversal
agent. In addition, the company is developing several mid-to-late...-stage therapies, including a copper-binding
agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare... -
Voir cette offre d'emploi